Published in Blood Weekly, March 21st, 2002
"Tumor-specific clonal immunoglobulin expressed by B-cell lymphomas (idiotype [Id]) can serve as a target for active immunotherapy," according to Dr. John M. Timmerman and colleagues at the Stanford University School of Medicine in Stanford, California.
After achieving promising results in a preliminary study with 4...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.